Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Filvaroff

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cytokine|October 24, 2001
Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivoL Cai, J P Yin, M A Starovasnik, et al.
The Journal of Endocrinology|October 6, 2000
Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cellsZ Q Cheng, S Adi, N Y Wu, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Effect of anti-TGF-beta antibodies in syngeneic mouse models of metastasisR Carano, Y Li, M Bao, et al.
The EMBO Journal|September 28, 2001
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor bindingS G Hymowitz, E H Filvaroff, J P Yin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphomaV Moreno, J M Sepulveda, M Vieito, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cytokine|October 24, 2001
Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivoL Cai, J P Yin, M A Starovasnik, et al.
The Journal of Endocrinology|October 6, 2000
Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cellsZ Q Cheng, S Adi, N Y Wu, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Effect of anti-TGF-beta antibodies in syngeneic mouse models of metastasisR Carano, Y Li, M Bao, et al.
The EMBO Journal|September 28, 2001
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor bindingS G Hymowitz, E H Filvaroff, J P Yin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphomaV Moreno, J M Sepulveda, M Vieito, et al.
Pageof 2